TVTX Historical PE Ratio image   This TVTX PE ratio history page last updated 8/8/2022
TVTX Historical PE Ratio Chart
PeriodPriceAdj. EPSAnnualizedPE
Q2 2022
8/4/2022
25.79-0.65-2.60NA
Q1 2022
5/5/2022
24.59-0.82-3.28NA
Q4 2021
2/24/2022
27.16-0.61-2.44NA
Q3 2021
10/28/2021
26.59-0.13-0.52NA
Q2 2021
7/29/2021
13.84-0.39-1.56NA
Q1 2021
5/6/2021
23.50-0.55-2.20NA
Q4 2020
3/1/2021
30.56-0.48-1.92NA
Q3 2020
11/5/2020
20.88-0.11-0.44NA
Q2 2020
7/30/2020
20.69-0.22-0.88NA
Q1 2020
5/11/2020
16.55-0.20-0.80NA
Q4 2019
2/24/2020
16.56-0.70-2.80NA
Q3 2019
10/30/2019
12.00-0.66-2.64NA
Q2 2019
8/6/2019
19.24-0.58-2.32NA
Q1 2019
5/7/2019
18.86-0.63-2.52NA
Q4 2018
2/26/2019
21.34-0.21-0.84NA
Q3 2018
11/1/2018
27.70-0.68-2.72NA
Q2 2018
7/26/2018
28.58-0.25-1.00NA
Q1 2018
5/1/2018
25.18-0.14-0.56NA
Q4 2017
2/27/2018
23.780.070.2884.9
Q3 2017
11/7/2017
25.23-0.46-1.84NA
Q2 2017
8/9/2017
20.500.030.12170.8
Q1 2017
5/4/2017
18.720.010.04468.0
Q4 2016
3/1/2017
21.500.000.00NA
Q3 2016
11/3/2016
18.60-0.09-0.36NA
Q2 2016
8/4/2016
18.770.070.2867.0
Q1 2016
5/3/2016
13.730.140.5624.5
Q4 2015
2/25/2016
14.600.070.2852.1
Q3 2015
11/3/2015
21.82-0.04-0.16NA
Q2 2015
8/4/2015
31.74-0.40-1.60NA
Q1 2015
5/11/2015
23.66-0.04-0.16NA
Q4 2014
3/5/2015
14.06-0.36-1.44NA
Q3 2014
11/13/2014
11.62-0.53-2.12NA
Q2 2014
8/12/2014
11.85-0.52-2.08NA
Q1 2014
5/14/2014
13.023.0312.121.1
FY 2013
3/27/2014
19.55-2.38-9.52NA
TVTX PE History Chart
PeriodPriceAdj. EPSTTMPE
Q2 2022
8/4/2022
25.79-0.65-2.21NA
Q1 2022
5/5/2022
24.59-0.82-1.95NA
Q4 2021
2/24/2022
27.16-0.61-1.68NA
Q3 2021
10/28/2021
26.59-0.13-1.55NA
Q2 2021
7/29/2021
13.84-0.39-1.53NA
Q1 2021
5/6/2021
23.50-0.55-1.36NA
Q4 2020
3/1/2021
30.56-0.48-1.01NA
Q3 2020
11/5/2020
20.88-0.11-1.23NA
Q2 2020
7/30/2020
20.69-0.22-1.78NA
Q1 2020
5/11/2020
16.55-0.20-2.14NA
Q4 2019
2/24/2020
16.56-0.70-2.57NA
Q3 2019
10/30/2019
12.00-0.66-2.08NA
Q2 2019
8/6/2019
19.24-0.58-2.10NA
Q1 2019
5/7/2019
18.86-0.63-1.77NA
Q4 2018
2/26/2019
21.34-0.21-1.28NA
Q3 2018
11/1/2018
27.70-0.68-1.00NA
Q2 2018
7/26/2018
28.58-0.25-0.78NA
Q1 2018
5/1/2018
25.18-0.14-0.50NA
Q4 2017
2/27/2018
23.780.07-0.35NA
Q3 2017
11/7/2017
25.23-0.46-0.42NA
Q2 2017
8/9/2017
20.500.03-0.05NA
Q1 2017
5/4/2017
18.720.01-0.01NA
Q4 2016
3/1/2017
21.500.000.12179.2
Q3 2016
11/3/2016
18.60-0.090.1997.9
Q2 2016
8/4/2016
18.770.070.2478.2
Q1 2016
5/3/2016
13.730.14-0.23NA
Q4 2015
2/25/2016
14.600.07-0.41NA
Q3 2015
11/3/2015
21.82-0.04-0.84NA
Q2 2015
8/4/2015
31.74-0.40-1.33NA
Q1 2015
5/11/2015
23.66-0.04-1.45NA
Q4 2014
3/5/2015
14.06-0.361.628.7
Q3 2014
11/13/2014
11.62-0.53-0.40NA
Q2 2014
8/12/2014
11.85-0.52NANA
Q1 2014
5/14/2014
13.023.03NANA
FY 2013
3/27/2014
19.55-2.38NANA
Quotes delayed 20 minutes

Email EnvelopeFree TVTX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Travere Therapeutics (TVTX) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

TVTY PE Ratio History
TWST PE Ratio History
TXG PE Ratio History
TXMD PE Ratio History
TYME PE Ratio History
TYRA PE Ratio History
UBX PE Ratio History
UFPT PE Ratio History
UHS PE Ratio History
UNCY PE Ratio History
How should the TVTX historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Travere Therapeutics. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this TVTX Historical PE Ratio page.

What is the average historical PE for TVTX based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The TVTX historical PE ratio using the annualized quarterly earnings method works out to 124.1.

What is the average historical PE for TVTX based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The TVTX historical PE ratio using the TTM earnings method works out to 91.0.

On this page we presented the TVTX Historical PE Ratio information for Travere Therapeutics' stock. The average TVTX historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 124.1. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average TVTX historical PE based on this TTM earnings result method is 91.0. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this TVTX historical PE result, against the recent PE: when this page was posted on 8/5/2022, the most recent closing price for TVTX had been 27.83, and the most recent quarterly earnings result, annualized, was 0.28. Meanwhile, the most recent TTM earnings summed to 0.12. From these numbers, we calculate the recent TVTX PE on 8/5/2022 based on annualized quarterly EPS was 99.4. Based on TVTX's history, that recent PE is low relative to the historical average, with the recent PE 19.9% lower than the historical average PE across our data set for Travere Therapeutics. Looking at the recent TVTX PE on 8/5/2022 based on TTM EPS, we calculate the ratio at 231.9. Based on TVTX's history, that recent PE is elevated relative to the historical average, with the recent PE 154.8% higher than the historical average PE across our Travere Therapeutics data set with TTM EPS used in the calculation at each period.

For self directed investors doing their due diligence on TVTX or any other given stock, valuation analysis for TVTX can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Travere Therapeutics PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for TVTX. Thanks for visiting, and the next time you need to research TVTX Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: GRX Options Chain, ATUS market cap history, PDFS Average Annual Return.

 

TVTX Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.